Medicare billing address
CMS Medicare provider billing file
1122 Street Rd Ste 204Southampton, PA 18966
CMS public data · NPI 1134488638
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Roman Bronfenbrener, MD
Specialty
Credential
MD
NPI
1134488638
Primary source state
PA
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Roman Bronfenbrener, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
1122 Street Rd Ste 204CMS Doctors & Clinicians file
1122 St RdCMS Doctors & Clinicians file
3400 Spruce StIn the 2024 CMS provider billing file, this NPI had 1,657 Medicare beneficiaries and 53,838 total services. The average beneficiary age was 77, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$2,373,551.93
Total Medicare payment amount
$1,838,365.49
Medicare beneficiaries
1,657
Total services
53,838
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Diabetes
46%
CMS beneficiary-panel share
Ischemic heart disease
39%
CMS beneficiary-panel share
Chronic kidney disease
24%
CMS beneficiary-panel share
Osteoporosis
24%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 28,500 | $1.66 |
| Destruction of precancer skin growth, 2-14 growths | 8,952 | $6.84 |
| Destruction of precancer skin growth, 1 growth | 2,061 | $42.67 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 1,400 | $131.31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,380 | $0.97 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 1,247 | $93.23 |
| Pathology examination of specimen during surgery, first tissue block | 560 | $103.17 |
| Destruction of skin growth, 1-14 growths | 352 | $94.11 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 347 | $95.43 |
| Biopsy of related skin growth, first growth | 335 | $77.46 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1134488638. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Ketoconazole | Ketoconazole | 3,057 | 3,164.9 | $52,105.59 |
| 2 | Betamethasone Dipropionate | Betamethasone Dipropionate | 714 | 760 | $32,784.93 |
| 3 | Triamcinolone Acetonide | Triamcinolone Acetonide | 660 | 700 | $8,206.41 |
| 4 | Fluocinonide | Fluocinonide | 634 | 684 | $25,535.67 |
| 5 | Nystatin | Nystatin | 349 | 373 | $7,186.72 |
| 6 | Ammonium Lactate | Ammonium Lactate | 331 | 354.5 | $5,320.08 |
| 7 | Metronidazole | Metronidazole | 303 | 321 | $21,692.44 |
| 8 | Minoxidil | Minoxidil | 218 | 335.7 | $1,179.75 |
| 9 | Dupixent Pen | Dupilumab | 201 | 204.5 | $770,217.03 |
| 10 | Doxycycline Hyclate | Doxycycline Hyclate | 187 | 236.2 | $2,993.91 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc)
Graduation year
2012
Group/practice field
Dermatology Specialists Of Pennsylvania
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Dermatology.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.